Publications:487
- Home
- Profiles
Accepting New Patients
Accepting New PatientsMark I Evans, MD
Obstetrics and Gynecology
No Patient Experience Ratings
Physician Office
212-288-1422
- About Me
- Education & Certifications
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Mark I. Evans, MD is Boarded in Clinical Genetics.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Mark I. Evans, MD is Boarded in Clinical Genetics.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
MD, SUNY Downstate Health Sciences University - College of Medicine
Residency, Obstetrics & Gynecology
University of Chicago Hospital
Residency, Obstetrics & Gynecology
Institution Not Present
Fellowship, Medical Genetics, Ph.D. Medical Genetics
National Cancer Institute, NIH
Certifications
American Board of Obstetrics and Gynecology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation. Sean W.D. Carter, Erin L. Fee, Haruo Usuda, Gokce Oguz, Adaikalavan Ramasamy, Zubair Amin, Biswas Agnihotri, Qin Wei, Liu Xiawen, Tsukasa Takahashi, Yuki Takahashi, Hideyuki Ikeda, Yusaku Kumagai, Yuya Saito, Masatoshi Saito, Citra Mattar, Mark I. Evans, Sebastián E. Illanes, Alan H. Jobe, Mahesh Choolani, Matthew W. Kemp. BMC Medicine
- Correction: Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation (BMC Medicine, (2024), 22, 1, (338), 10.1186/s12916-024-03542-5). Sean W.D. Carter, Erin L. Fee, Haruo Usuda, Gokce Oguz, Adaikalavan Ramasamy, Zubair Amin, Biswas Agnihotri, Qin Wei, Liu Xiawen, Tsukasa Takahashi, Yuki Takahashi, Hideyuki Ikeda, Yusaku Kumagai, Yuya Saito, Masatoshi Saito, Citra Mattar, Mark I. Evans, Sebastián E. Illanes, Alan H. Jobe, Mahesh Choolani, Matthew W. Kemp. BMC Medicine
- Reframing antepartum and intrapartum surveillance. Lawrence D. Devoe, David W. Britt, Mark I. Evans. Best Practice and Research: Clinical Obstetrics and Gynaecology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Evans during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- KLS LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Evans during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- KLS LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.